Cover Image
市場調查報告書

結核檢驗市場(各檢驗類型:胸部X光掃描、培養檢驗、IGRA、結核菌素反應、核酸檢驗、Xpert檢驗、血清學的檢驗、其他、各終端用戶)- 全球產業分析、規模、佔有率、成長、趨勢、2017∼2025年的預測

Tuberculosis Testing Market (Test Type - Chest X-Ray, Culture Based Tests, IGRA, Mantoux Test, Nucleic Acid Testing, Xpert Test, Serological Tests, & Others; End-User - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2025

出版商 Transparency Market Research 商品編碼 581345
出版日期 內容資訊 英文 197 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
結核檢驗市場(各檢驗類型:胸部X光掃描、培養檢驗、IGRA、結核菌素反應、核酸檢驗、Xpert檢驗、血清學的檢驗、其他、各終端用戶)- 全球產業分析、規模、佔有率、成長、趨勢、2017∼2025年的預測 Tuberculosis Testing Market (Test Type - Chest X-Ray, Culture Based Tests, IGRA, Mantoux Test, Nucleic Acid Testing, Xpert Test, Serological Tests, & Others; End-User - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2025
出版日期: 2017年10月30日 內容資訊: 英文 197 Pages
簡介

本報告提供全球結核檢驗市場相關調查,至2025年的預測,各檢驗類型、各終端用戶、各地區的趨勢,及打入市場的主要企業的簡介等彙整資料。

第1章 序論

第2章 假設和調查方法

第3章 摘要整理

第4章 市場概要

  • 簡介
  • 概要
  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 機會
    • 趨勢
  • 市場分析與預測
  • 市場預測
  • 波特五力分析
  • 全球結核市場趨勢
  • 傳統的檢驗/診斷方法的課題
  • 熱圖分析
  • IGRA
  • 塗片顯微鏡檢驗
  • 核酸檢驗
  • 結核菌素反應
  • 胸部X光掃描
  • DST
  • 培養檢驗
  • 其他
  • 對全球結核的研發支出
  • 結核診斷檢驗開發平台
  • 結核分子診斷開發的進展概要
  • 使用了GRADE的WHO推薦的結核診斷開發、評估階段

第5章 各檢驗類型市場分析

  • 主要調查結果/發展
  • 簡介、定義
  • 市場價值佔有率分析
  • 市場預測
    • 胸部X光掃描
    • 培養檢驗
    • IGRA
    • 結核菌素反應
    • 核酸檢驗
    • 血清學的檢驗
    • 塗片顯微鏡檢驗
    • 其他
  • 市場魅力度

第6章 各終端用戶市場分析

  • 主要調查結果/發展
  • 簡介、定義
  • 市場價值佔有率分析
  • 市場預測
    • 醫院
    • 參照實驗室
    • 診療所
    • 學術研究機關
    • 其他
  • 市場魅力度

第7章 各地區市場分析

  • 市場收益預測
  • 簡介
  • 市場價值佔有率分析
  • 市場預測
  • 市場魅力度

第8章 北美

第9章 歐洲

第10章 亞太地區

第11章 南美

第12章 中東、非洲

第13章 地區/國家概要

第14章 競爭環境

  • 市場參與企業的競爭矩陣
  • 企業簡介
    • Thermo Fisher Scientific, Inc.
    • Alere, Inc.
    • Becton, Dickinson and Company
    • F. Hoffmann-La Roche AG
    • LIONEX Diagnostics & Therapeutics GmbH.
    • Danaher Corporation
    • Creative Diagnostics
    • QIAGEN
    • Hain Lifescience GmbH
    • Oxford Immunotec Ltd.
    • Hologic, Inc.
    • Cepheid
    • Akonni Biosystems, Inc.
    • bioMerieux SA
    • Epistem Ltd.
目錄

Global Tuberculosis Testing Market: Overview

Tuberculosis testing can be defined as the most commonly used diagnostic tools for the tuberculosis. Tuberculosis is defined as an infectious disease which characterized by development of tubercles (nodules) in the body tissues, especially in the lungs. The market is anticipated to grow at a significant rate owing to various factors such as high return on investments, first-mover advantage to the tuberculosis test kits manufacturers, growing focus on awareness programs by the governmental and non-governmental organizations, and tax credits and fee waivers offered by the government, among others.

The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of tests employed in the diagnosis of tuberculosis in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases. The report provides estimated market size in terms of US$ Mn for test type, end-user, and geography for the period 2015 to 2025, considering the macro and micro environmental factors. The revenue generated from each test type, and end-user was calculated by considering the prevalence of tuberculosis, testing approvals, regulatory procedures, and the awareness of tuberculosis across all the geographies.

Global Tuberculosis Testing Market: Segmentation

The market report comprises an elaborated executive summary, which includes market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to market segments based on test type, end-user, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints and opportunities that influences the tuberculosis testing market in the current and future scenario. The report also provides Porter's five forces analysis, the acquisitions timeline of tuberculosis testing companies, SWOT analysis of the market, regulatory scenario, comparative analysis of tuberculosis testing policies, tuberculosis prevalence globally, pricing scenario of the tuberculosis testing, and major used tuberculosis tests.

Global Tuberculosis Testing Market: Competitive Analysis

Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors will help the market players to decide about the business strategies and plans to strengthen their positions in the global market. Based on geography, the market has been analyzed for major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The study also covers detailed country analysis contributing majorly in the tuberculosis testing market.

The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Companies profiled in the tuberculosis testing market report are Becton, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Hain Lifescience GmbH, Hologic Inc., Abbott Laboratories, Alere Inc., Epistem plc, Cepheid, bioMerieux SA, Akonni Biosystems Inc., LIONEX Diagnostics & Therapeutics GmbH., Danaher Corporation, Creative Diagnostics, QIAGEN, and Oxford Immunotec Ltd. among others.

The Tuberculosis Testing Market has been segmented as follows:

Global Tuberculosis Testing Market, by Test Type

  • Chest X-Ray
  • Culture Based Tests
  • IGRA (Interferon-Gamma Release Assays)
  • Mantoux Test (TST)
  • Nucleic Acid Testing (NAT), Xpert test
  • Serological Tests
  • Smear Microscopy
  • Other Tests (ADA, etc.)

Global Tuberculosis Testing Market, by End-User, Revenue

  • Academics and Research
  • Hospitals Laboratories
  • Physician's Office Laboratories
  • Reference Laboratories
  • Others (Home Health Agencies, etc.)

Global Tuberculosis Testing Market Revenue, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of MEA

Table of Contents

Section 1 Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

Section 2 Assumptions and Research Methodology

Section 3 Executive Summary

Section 4 Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Type Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
      • 4.3.1.1. Increase in case detection rate in worldwide
      • 4.3.1.2. Rise in prevalence of drug resistant tuberculosis infection
      • 4.3.1.3. Improvement in bacteriological confirmation
      • 4.3.1.4. Rise in awareness enabling proper disease management
      • 4.3.1.5. Rising demand for improved and technologically advanced tuberculosis testing procedures
      • 4.3.1.6. Tuberculosis awareness and control programs
    • 4.3.2. Restraints
      • 4.3.2.1. Challenges of Mantoux test
      • 4.3.2.2. High cost of various tuberculosis tests
    • 4.3.3 Opportunities
      • 4.3.3.1. Impact of novel tests on the overall market
      • 4.3.3.2. High potential market for affordable and more effective TB tests
    • 4.3.4. Trends
  • 4.5. Global Tuberculosis Testing Market Analysis and Forecasts, 2015-2025
  • 4.6. Market Outlook
  • 4.7. Porter's Five Forces Analysis
  • 4.8. Burden of TB Worldwide
  • 4.9. Burden of MDR-TB Worldwide
  • 4.10. Challenges of Traditional Testing/Diagnostic Methods
  • 4.11. Heat Map Analysis -Company
  • 4.12. IGRA (Interferon Gamma Release Assay)
  • 4.13. Smear Microscopy Tests
  • 4.14. Nucleic Acid Testing (NAT)
  • 4.15. Mantoux Test (Tuberculin Test)
  • 4.16. Chest X-Ray
  • 4.17. DST (Drug Susceptibility Testing)
  • 4.18. Culture based method
  • 4.19. Other Tests
  • 4.20. Global R&D spending on Tuberculosis
  • 4.21. Global Changes in TB R&D Funding, 2005-2015
  • 4.22. Global R&D funding on Tuberculosis By Funders
  • 4.23. Tuberculosis Diagnostic Tests Pipeline
  • 4.24. An overview of progress in the development of molecular TB diagnostics
  • 4.25. The phases of TB diagnostics development and assessment for WHO recommendation using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) process

Section 5 Global Tuberculosis Testing Market Analysis, by Test Type

  • 5.1. Key Findings / Developments
  • 5.2. Introduction & Definition
  • 5.3. Global Tuberculosis Testing Market Value Share Analysis, by Test Type
  • 5.4. Global Tuberculosis Testing Market Forecast, by Test Type
    • 5.4.1. Chest X-Ray
    • 5.4.2. Culture Based Tests
    • 5.4.3. IGRA
    • 5.4.4. Mantoux Test (TST)
    • 5.4.5. Nucleic Acid Testing (NAT), Xpert test
    • 5.4.6. Serological Tests
    • 5.4.7. Smear Microscopy
    • 5.4.8. Other Tests (ADA, etc.)
  • 5.5. Global Tuberculosis Testing Market Attractiveness, by Test Type

Section 6 Global Tuberculosis Testing Market Analysis, by End-User

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Global Tuberculosis Testing Market Value Share Analysis, by End-User
    • 6.4.1. Global Tuberculosis Testing Market Forecast, by End-user
      • 6.4.2.1. Hospitals Laboratories
      • 6.4.3.2. Reference Laboratories
      • 6.4.4.3. Physician's Office Laboratories
      • 6.4.5.4. Academics and Research Institutes
      • 6.4.6.5. Others (home health agencies, etc.)
    • 6.4.7. Global Tuberculosis Testing Market Attractiveness, by End-User

Section 7 Global Tuberculosis Testing Market Analysis, by Region

  • 7.1. Global Tuberculosis Testing Market Revenue Forecast, 2015-2025
  • 7.2. Introduction
  • 7.3. Global Tuberculosis Testing Market Value Share Analysis, by Region
  • 7.4. Global Tuberculosis Testing Market Forecast, by Region
  • 7.5. Global Tuberculosis Testing Market Attractiveness, by Region

Section 8 North America Tuberculosis Testing Market Analysis

  • 8.1. Introduction
  • 8.2. Key Findings
  • 8.3. North America Tuberculosis Testing Market Overview
  • 8.4. North America Tuberculosis Testing Market Value Share Analysis, by Country
    • 8.4.1. U.S.
    • 8.4.2. Canada
  • 8.5. North America Tuberculosis Testing Market Forecast, by Country
    • 8.6.1. North America Tuberculosis Testing Market Value Share Analysis, by Test Type
    • 8.6.2. Chest X-Ray
    • 8.6.3. Culture Based Tests
    • 8.6.4. IGRA (Interferon-Gamma Release Assays)
    • 8.6.5. Mantoux Test (TST)
    • 8.6.6. Nucleic Acid Testing (NAT), Xpert test
    • 8.6.6. Serological Tests
    • 8.6.8. Smear Microscopy
    • 8.6.9. Other Tests (ADA, etc.)
  • 8.7. North America Tuberculosis Testing Market Forecast, by Test Type
  • 8.8. North America Tuberculosis Testing Market Value Share Analysis, by End-User
    • 8.8.1. Academics and Research
    • 8.8.2. Hospitals Laboratories
    • 8.8.3. Physician's Office Laboratories
    • 8.8.4. Reference Laboratories
    • 8.8.5. Others (Home Health Agencies, etc.)
  • 8.9. North America Tuberculosis Testing Market Forecast, by End-User
  • 8.10. North America Tuberculosis Testing Market Attractiveness Analysis

Section 9 Europe Tuberculosis Testing Market Analysis

  • 9.1. Introduction
  • 9.2. Key Findings
  • 9.3. Europe Tuberculosis Testing Market Overview
  • 9.4. Europe Tuberculosis Testing Market Value Share Analysis, by Country
    • 9.4.1. Germany
    • 9.4.2. U.K.
    • 9.4.3. France
    • 9.4.4. Italy
    • 9.4.5. Spain
    • 9.4.6. Rest of Europe
  • 9.5. Europe Tuberculosis Testing Market Forecast, by Country
  • 9.6. Europe Tuberculosis Testing Market Value Share Analysis, by Test Type
    • 9.6.1. Chest X-Ray
    • 9.6.2. Culture Based Tests
    • 9.6.3. IGRA (Interferon-Gamma Release Assays)
    • 9.6.4. Mantoux Test (TST)
    • 9.6.5. Nucleic Acid Testing (NAT), Xpert test
    • 9.6.6. Serological Tests
    • 9.6.7. Smear Microscopy
    • 9.6.8. Other Tests (ADA, etc.)
  • 9.7. Europe Tuberculosis Testing Market Forecast, by Test Type
  • 9.8. Europe Tuberculosis Testing Market Value Share Analysis, by End-User
    • 9.8.1. Academics and Research
    • 9.8.2. Hospitals Laboratories
    • 9.8.3. Physician's Office Laboratories
    • 9.8.4. Reference Laboratories
    • 9.8.5. Others (Home Health Agencies, etc.)
  • 9.9. Europe Tuberculosis Testing Market Forecast, by End-User
  • 9.10. Europe Tuberculosis Testing Market Attractiveness Analysis

Section 10 Asia Pacific Tuberculosis Testing Market Analysis

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Asia Pacific Tuberculosis Testing Market Overview
  • 10.4. Asia Pacific Tuberculosis Testing Market Value Share Analysis, by Country
    • 10.4.1. China
    • 10.4.2. India
    • 10.4.3. Japan
    • 10.4.4. Australia & New Zealand
    • 10.4.5. Rest of Asia Pacific
  • 10.5. Asia Pacific Tuberculosis Testing Market Forecast, by Country
  • 10.6. Asia Pacific Tuberculosis Testing Market Value Share Analysis, by Test Type
    • 10.6.1. Chest X-Ray
    • 10.6.2. Culture Based Tests
    • 10.6.3. IGRA (Interferon-Gamma Release Assays)
    • 10.6.4. Mantoux Test (TST)
    • 10.6.5. Nucleic Acid Testing (NAT), Xpert test
    • 10.6.6. Serological Tests
    • 10.6.7. Smear Microscopy
    • 10.6.8. Other Tests (ADA, etc.)
  • 10.7. Asia Pacific Tuberculosis Testing Market Forecast, by Test Type
  • 10.8. Asia Pacific Tuberculosis Testing Market Value Share Analysis, by End-User
    • 10.8.1. Academics and Research
    • 10.8.2. Hospitals Laboratories
    • 10.8.3. Physician's Office Laboratories
    • 10.8.4. Reference Laboratories
    • 10.8.5. Others (Home Health Agencies, etc.)
  • 10.9. Asia Pacific Tuberculosis Testing Market Forecast, by End-User
  • 10.10. Asia Pacific Tuberculosis Testing Market Attractiveness Analysis

Section 11 Latin America Tuberculosis Testing Market Analysis

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Latin America Tuberculosis Testing Market Overview
  • 11.4. Latin America Tuberculosis Testing Market Value Share Analysis, by Country
    • 11.4.1. Brazil
    • 11.4.2. Mexico
    • 11.4.3. Rest of LATAM
  • 11.5. Latin America Tuberculosis Testing Market Forecast, by Country
  • 11.6. Latin America Tuberculosis Testing Market Value Share Analysis, by Test Type
    • 11.6.1. Chest X-Ray
    • 11.6.2. Culture Based Tests
    • 11.6.3. IGRA (Interferon-Gamma Release Assays)
    • 11.6.4. Mantoux Test (TST)
    • 11.6.5. Nucleic Acid Testing (NAT), Xpert test
    • 11.6.6. Serological Tests
    • 11.6.7. Smear Microscopy
    • 11.6.8. Other Tests (ADA, etc.)
  • 11.7. Latin America Tuberculosis Testing Market Forecast, by Test Type
  • 11.8. Latin America Tuberculosis Testing Market Value Share Analysis, by End-User
    • 11.8.1. Academics and Research
    • 11.8.2. Hospitals Laboratories
    • 11.8.3. Physician's Office Laboratories
    • 11.8.4. Reference Laboratories
    • 11.8.5. Others (Home Health Agencies, etc.)
  • 11.9. Latin America Tuberculosis Testing Market Forecast, by End-User
  • 11.10. Latin America Tuberculosis Testing Market Attractiveness Analysis

Section 12 Middle East and Africa Tuberculosis Testing Market Analysis

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Middle East and Africa Tuberculosis Testing Market Overview
  • 12.4. Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by Country
    • 12.4.1. GCC Countries
    • 12.4.2. South Africa
    • 12.4.3. Rest of MEA
  • 12.5. Middle East and Africa Tuberculosis Testing Market Forecast, by Country
  • 12.6. Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by Test Type
    • 12.6.1. Chest X-Ray
    • 12.6.2. Culture Based Tests
    • 12.6.3. IGRA (Interferon-Gamma Release Assays)
    • 12.6.4. Mantoux Test (TST)
    • 12.6.5. Nucleic Acid Testing (NAT), Xpert test
    • 12.6.6. Serological Tests
    • 12.6.7. Smear Microscopy
    • 12.6.8. Other Tests (ADA, etc.)
  • 12.7. Middle East and Africa Tuberculosis Testing Market Forecast, by Test Type
  • 12.8. Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by End-User
    • 12.8.1. Academics and Research
    • 12.8.2. Hospitals Laboratories
    • 12.8.3. Physician's Office Laboratories
    • 12.8.4. Reference Laboratories
    • 12.8.5. Others (Home Health Agencies, etc.)
  • 12.9. Middle East and Africa Tuberculosis Testing Market Forecast, by End-User
  • 12.10. Middle East and Africa Tuberculosis Testing Market Attractiveness Analysis

Section 13 Region/Country Snippets

Section 14 Competition Landscape

  • 14.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 14.2. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
    • 14.2.1. Thermo Fisher Scientific, Inc.
    • 14.2.2. Alere, Inc.
    • 14.2.3. Becton, Dickinson and Company
    • 14.2.4. F. Hoffmann-La Roche AG
    • 14.2.5. LIONEX Diagnostics & Therapeutics GmbH.
    • 14.2.6. Danaher Corporation
    • 14.2.7. Creative Diagnostics
    • 14.2.8. QIAGEN
    • 14.2.9. Hain Lifescience GmbH
    • 14.2.10. Oxford Immunotec Ltd.
    • 14.2.11. Hologic, Inc.
    • 14.2.12. Cepheid
    • 14.2.13. Akonni Biosystems, Inc.
    • 14.2.14. bioMerieux SA
    • 14.2.15. Epistem Ltd.

List of Tables

  • Table 01: Top 10 High TB burden countries with estimated number of new TB cases globally
  • Table 02: Estimated number of MDR-TB among all notified TB cases in high burden countries (2015)
  • Table 03: TB R&D Funders by Rank in 2015
  • Table 04: Tuberculosis Diagnostics tests Pipeline
  • Table 05: Global Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2015-2025
  • Table 06: Global Tuberculosis Testing Market Value (US$ Mn) Forecast, by End-user, 2015-2025
  • Table 07: Global Tuberculosis Testing Market Size (US$ Mn) Forecast, by Region, 2015-2025
  • Table 08: North America Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 09: North America Tuberculosis Testing Market Size (US$ Bn) Forecast, by Test Type, 2015-2025
  • Table 10: North America Tuberculosis Testing Market Size (US$ Bn) Forecast, by End-User, 2015-2025
  • Table 11: Europe Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 12: Europe Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2015-2025
  • Table 13: Europe Tuberculosis Testing Market Size (US$ Bn) Forecast, by End-User, 2015-2025
  • Table 14: Asia Pacific Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 15: Asia Pacific Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2015-2025
  • Table 16: Asia Pacific Tuberculosis Testing Market Size (US$ Mn) Forecast, by End-User, 2015-2025
  • Table 17: Latin America Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 18: Latin America Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2015-2025
  • Table 19: Latin America Tuberculosis Testing Market Size (US$ Mn) Forecast, by End-User, 2015-2025
  • Table 20: Middle East and Africa Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 21: Middle East and Africa Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2015-2025
  • Table 22: Middle East and Africa Tuberculosis Testing Market Size (US$ Mn) Forecast, by End-User, 2015-2025

List of Figures

  • Figure 01: Global Tuberculosis Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2025
  • Figure 02: Market Value Share, by Test Type (2016)
  • Figure 03: Market Value Share, by End User (2016)
  • Figure 04: Market Value Share, by Region (2016)
  • Figure 05: Annual Global Plan Research Funding Targets versus 2015 Funding on Tuberculosis
  • Figure 06: Total TB R&D Funding, 2005-2015
  • Figure 07: Total TB R&D Funding by Funder Category, 2015
  • Figure 08: Total TB R&D Funding by Funder Category, 2005-2015 (Mn)
  • Figure 09: Global Tuberculosis Testing Market Value Share Analysis, by Test Type, 2016 and 2025
  • Figure 10: Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Chest X-Ray, 2015-2025
  • Figure 11: Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Culture Based Tests,
  • Figure 12: Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by IGRA, 2015-2025
  • Figure 13: Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Mantoux Test (TST), 2015-2025
  • Figure 14: Global Tuberculosis Testing Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Nucleic Acid Testing (NAT), Xpert test, 2015-2025
  • Figure 15: Global Tuberculosis Testing Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Serological Tests,
  • Figure 16: Global Tuberculosis Testing Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Smear Microscopy, 2015-2025
  • Figure 17: Global Tuberculosis Testing Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Other Tests (ADA, etc.), 2015-2025
  • Figure 18: Global Tuberculosis Testing Market Attractiveness, by Test Type, 2017-2025
  • Figure 19: Global Tuberculosis Testing Market Value Share Analysis, by End-User, 2016 and 2025
  • Figure 20: Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2015-2025
  • Figure 21: Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Reference Laboratories, 2015-2025
  • Figure 22: Europe Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Physician's Office Laboratories, 2015-2025
  • Figure 23: Europe Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Academics and Research, 2015-2025
  • Figure 24: Europe Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015-2025
  • Figure 25: Global Tuberculosis Testing Market Attractiveness, by End-User, 2017-2025
  • Figure 26: Global Tuberculosis Testing Market Revenue (US$ Bn) Forecast, 2015-2025
  • Figure 27: Global Tuberculosis Testing Market Value Share Analysis, by Region, 2016 and 2025
  • Figure 28: Global Tuberculosis Testing Market Attractiveness, by Region, 2017-2025
  • Figure 29: North America Tuberculosis Testing Market Size (US$ Bn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • Figure 30: North America Tuberculosis Testing Market Attractiveness Analysis, by Country, 2017-2025
  • Figure 31: North America Tuberculosis Testing Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 32: North America Tuberculosis Testing Market Value Share Analysis, by Test Type, 2016 and 2025
  • Figure 33: North America Tuberculosis Testing Market Value Share Analysis, by End-User, 2016 and 2025
  • Figure 34: North America Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2017-2025
  • Figure 35: North America Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2017-2025
  • Figure 36: Europe Tuberculosis Testing Market Size (US$ Bn) Forecast, 2015-2025
  • Figure 37: Europe Market Attractiveness Analysis, by Country, 2017-2025
  • Figure 38: Europe Tuberculosis Testing Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 39: Europe Tuberculosis Testing Market Value Share Analysis, by Test Type, 2016 and 2025
  • Figure 40: Europe Tuberculosis Testing Market Value Share Analysis, by End-User, 2016 and 2025
  • Figure 41: Europe Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2017-2025
  • Figure 42: Europe Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2017-2025
  • Figure 43: Asia Pacific Tuberculosis Testing Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • Figure 44: Asia Pacific Tuberculosis Testing Market Attractiveness Analysis, by Country, 2017-2025
  • Figure 45: Asia Pacific Tuberculosis Testing Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 46: Asia Pacific Tuberculosis Testing Market Value Share Analysis, by Test Type, 2016 and 2025
  • Figure 47: Asia Pacific Tuberculosis Testing Market Value Share Analysis, by End-User, 2016 and 2025
  • Figure 48: Asia Pacific Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2017-2025
  • Figure 49: Asia Pacific Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2017-2025
  • Figure 50: Latin America Tuberculosis Testing Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • Figure 51: Latin America Tuberculosis Testing Market Attractiveness Analysis, by Country, 2017-2025
  • Figure 52: Latin America Tuberculosis Testing Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 53: Latin America Tuberculosis Testing Market Value Share Analysis, by Test Type, 2016 and 2025
  • Figure 54: Latin America Tuberculosis Testing Market Value Share Analysis, by End-User, 2016 and 2025
  • Figure 55: Latin America Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2017-2025
  • Figure 56: Latin America Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2017-2025
  • Figure 57: Middle East and Africa Tuberculosis Testing Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • Figure 58: Middle East and Africa Tuberculosis Testing Market Attractiveness Analysis, by Country, 2017-2025
  • Figure 59: Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 60: Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by Test Type, 2016 and 2025
  • Figure 61: Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by End-User, 2016 and 2025
  • Figure 62: Middle East and Africa Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2017-2025
  • Figure 63: Middle East and Africa Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2017-2025
  • Figure 64: Thermo Fisher Scientific, Inc. - Breakdown of Net Sales (% Share), by Business segments (2016)
  • Figure 65: Thermo Fisher Scientific, Inc. - Revenue (US$ Mn) and Y-o-Y Growth (%), 2013-2016
  • Figure 66: Alere, Inc. - Revenue Split, by Operating Segment, 2015
  • Figure 67: Alere, Inc. - Total Revenue (US$ Bn) and Y-o-Y Growth (%), 2014-2016
  • Figure 68: Becton, Dickinson and Company - Breakdown of Net Sales, by Region, 2016
  • Figure 69: Becton, Dickinson and Company- Revenue (US$ Mn) and Y-o-Y Growth (%), 2013-2016
  • Figure 70: F. Hoffmann-La Roche AG Breakdown of Net Sales (Pharmaceutical Division), by Region, 2015
  • Figure 71: F. Hoffmann-La Roche AG- Revenue (US$ Bn) & Y-o-Y Growth (%), 2013-2016
  • Figure 72: Danaher Corporation - Breakdown of Revenue, by Region, 2016
  • Figure 73: Danaher Corporation - Revenue (US$ Bn) & Y-o-Y Growth (%), 2012-2016
  • Figure 74: QIAGEN- Breakdown of Net Sales, by Business Segment, 2016
  • Figure 75: QIAGEN- Revenue (US$ Bn) and Y-o-Y Growth (%), 2013-2016
  • Figure 76: Oxford Immunotec Ltd. - Breakdown of Net Sales, by region, 2015
  • Figure 77: Oxford Immunotec Ltd. - Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2016
  • Figure 78: Hologic, Inc. - Breakdown of Net Sales, by Country/Region, 2015
  • Figure 79: Hologic, Inc. - Revenue (US$ Mn) and Y-o-Y Growth (%), 2012-2015
  • Figure 80: Cepheid - Breakdown of Net Sales, by Country/Region, 2015
  • Figure 81: Cepheid - Revenue (US$ Mn) and Y-o-Y Growth (%), 2012-2015
  • Figure 82: bioMerieux SA - Breakdown of Net Sales, by Country/Region, 2016
  • Figure 83: bioMerieux SA - Revenue (US$ Mn) and Y-o-Y Growth (%), 2012-2015
  • Figure 84: Epistem Ltd. - Breakdown of Net Sales, by Country/Region, 2015
  • Figure 85: Epistem Ltd. - Revenue (US$ Mn) and Y-o-Y Growth (%), 2012-2015
Back to Top